Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Visualized Experiments : Jove
|
April 14, 2015
Tracking mouse bone marrow monocytes in vivo
Pauline Hamon, Mathieu Paul Rodero, Christophe Combadière, et al.
Neoplasia (New York, N.Y.)
|
June 5, 2013
Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice
Mathieu Paul Rodero, Constance Auvynet, Lucie Poupel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 7, 2017
Interleukin-23 regulates interleukin-17 expression in wounds, and its inhibition accelerates diabetic wound healing through the alteration of macrophage polarization
James Lee, Mathieu Paul Rodero, Jatin Patel, et al.
Journal of Clinical Immunology
|
August 24, 2021
Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection
Mathieu Paul Rodero, Stéphane Pelleau, Anne Welfringer-Morin, et al.
Journal of Clinical Immunology
|
October 8, 2021
Correction to: Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection
Mathieu Paul Rodero, Stéphane Pelleau, Anne Welfringer-Morin, et al.
The Journal of Investigative Dermatology
|
November 14, 2024
Increased Mortality in Patients with Diffuse Systemic Sclerosis with High Circulating IFNα Levels
François Maillet, Carine Schmidt, Vincent Bondet, et al.
Frontiers in Immunology
|
July 28, 2020
Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
Vincent Gies, Nassima Bekaddour, Yannick Dieudonné, et al.
Cells
|
June 25, 2025
Muscle Spatial Transcriptomic Reveals Heterogeneous Profiles in Juvenile Dermatomyositis and Persistence of Abnormal Signature After Remission
Margot Tragin, Séverine A Degrelle, Baptiste Periou, et al.
The Journal of Allergy and Clinical Immunology
|
August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children
Marie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Visualized Experiments : Jove
|
April 14, 2015
Tracking mouse bone marrow monocytes in vivo
Pauline Hamon, Mathieu Paul Rodero, Christophe Combadière, et al.
Neoplasia (New York, N.Y.)
|
June 5, 2013
Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice
Mathieu Paul Rodero, Constance Auvynet, Lucie Poupel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 7, 2017
Interleukin-23 regulates interleukin-17 expression in wounds, and its inhibition accelerates diabetic wound healing through the alteration of macrophage polarization
James Lee, Mathieu Paul Rodero, Jatin Patel, et al.
Journal of Clinical Immunology
|
August 24, 2021
Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection
Mathieu Paul Rodero, Stéphane Pelleau, Anne Welfringer-Morin, et al.
Journal of Clinical Immunology
|
October 8, 2021
Correction to: Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection
Mathieu Paul Rodero, Stéphane Pelleau, Anne Welfringer-Morin, et al.
The Journal of Investigative Dermatology
|
November 14, 2024
Increased Mortality in Patients with Diffuse Systemic Sclerosis with High Circulating IFNα Levels
François Maillet, Carine Schmidt, Vincent Bondet, et al.
Frontiers in Immunology
|
July 28, 2020
Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
Vincent Gies, Nassima Bekaddour, Yannick Dieudonné, et al.
Cells
|
June 25, 2025
Muscle Spatial Transcriptomic Reveals Heterogeneous Profiles in Juvenile Dermatomyositis and Persistence of Abnormal Signature After Remission
Margot Tragin, Séverine A Degrelle, Baptiste Periou, et al.
The Journal of Allergy and Clinical Immunology
|
August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children
Marie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
Page
of 1